Skip to main content

Table 1 Baseline Demographic and Clinical Characteristics*

From: Mobile health, exercise and metabolic risk: a randomized controlled trial

Characteristic

Intervention (n =75)

Active Control (n =74)

Demographics

  

Age (years)

55.7 (10.1)

57.8 (8.7)

Sex (female)

55 (73.3%)

56 (75.7%)

Race (Caucasian)

74 (100%)

73 (100%)

Smoking status:

  

 Current

3 (4.0%)

1 (1.4%)

 Former

31 (41.3%)

29 (39.2%)

History of Type 2 Diabetes

3 (4.0%)

4 (5.4%)

Antihypertensive Therapy

27 (36.0%)

33 (44.6%)

 Monotherapy

16 (59.3%)

21 (63.6%)

 Combination Therapy

11 (40.7%)

12 (36.3%)

 Angiotensin Converting

  

 Enzyme Inhibitors

10 (37.0%)

20 (60.6%)

 Angiotensin Receptor Blockers

6 (22.2%)

10 (30.3%)

 Calcium Channel Blockers

4 (14.8%)

1 (3.0%)

 Diuretics

17 (63.0%)

15 (45.4%)

 Alpha Receptor Blockers

1 (3.7%)

0 (0%)

Average frequency of physical activity (in last 7 days), median (IQR)

2.5 (3.5)

3.0 (4.0)

pVO2max

30.5 (6.8)

31.2 (6.3)

  1. Abbreviations: IQR interquartile range, pVO 2max predicted maximal oxygen uptake (aerobic fitness).
  2. *Data are means (SD) or numbers (%) unless otherwise indicated. Percentages are calculated excluding missing values.
  3. Missing values: Intervention (n = 1) and Active Control (n = 1).
  4. Average of: (a) number days (in last 7) that at least 30 minutes of continuous physical activity was done and b) number of days (in last 7) participated in a specific exercise session.